PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

#ClientFilingsTotal $
1PFIZER INC.PFE47$46.8M
2GENERAL MOTORS COMPANYGM61$46.8M
3META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA12$44.9M
4VISA INC.V45$37.7M
5AMAZON.COM SERVICES LLCAMZN36$32.8M
6LOCKHEED MARTIN CORPORATIONLMT73$29.0M
7FEDEX CORPORATIONFDX69$27.8M
8ELI LILLY AND COMPANYLLY56$27.1M
9ALTRIA CLIENT SERVICES LLCMO142$25.2M
10AMGEN INCAMGN19$24.9M
11COMCAST CORPORATIONCMCSV179$24.7M
12MERCK & CO INCMRK14$24.0M
13SOUTHERN COMPANYSO53$23.9M
14GOOGLE CLIENT SERVICES LLCGOOGL79$22.6M
15APPLE INCAAPL9$22.1M
16T-MOBILE USA INC.TMUS121$21.0M
17UNITEDHEALTH GROUP INCUNH19$20.4M
18VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ40$20.1M
19OCCIDENTAL PETROLEUM CORPORATIONOXY30$19.7M
20MICROSOFT CORPORATIONMSFT103$18.8M
21QUALCOMM INCORPORATEDQCOM40$17.2M
22GENERAL DYNAMICS CORPGD11$17.0M
23BOEING COMPANYBA23$16.9M
24THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI13$16.9M
25ORACLE CORPORATIONORCL58$16.7M

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · REGENERON PHARMACEUTICALS INC.

clear filters
DateTickerClientRegistrantAmountIssue
2026-05-04REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense and Medicare prescription drug funding
2026-04-20REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2026-04-20REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0Outreach related to FY 2027 appropriations. Outreach related to FY 2027 appropriations.
2026-04-15REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2026-04-01REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174.
2026-01-21REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2026-01-20REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2026-01-20REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2026-01-16REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302)
2026-01-16REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-10-20REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2025-10-20REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2025-10-16REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-10-14REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302, 70604)
2025-10-01REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2025-07-21REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2025-07-20REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2025-07-17REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-07-11REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP (FORMERLY THE WASHINGTON TAX GROUP)$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302, 70604)
2025-07-10REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$0Provide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2025-07-01REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2025-05-05REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2025-04-21REGNREGENERON PHARMACEUTICALS INC.STEWART STRATEGIES AND SOLUTIONS, LLC$60K
2025-04-21REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$30KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2025-04-21REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-04-17REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), 174 and 41. (H.R. 1990)
2025-03-27REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$0Issues related to healthcare.
2025-02-07REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$0Issues related to corporate and international tax
2025-01-21REGNREGENERON PHARMACEUTICALS INC.STEWART STRATEGIES AND SOLUTIONS, LLC$60K